Mark Walport

Source: Wikipedia, the free encyclopedia.

FRSE
Mark Walport
Born
Mark Jeremy Walport

(1953-01-25) 25 January 1953 (age 71)[3]
London, England
EducationSt Paul's School, London
Alma materUniversity of Cambridge (PhD)[3]
Known for
Spouse
Julia Elizabeth Neild
​
​
(m. 1986)​
[3]
Childrenone son, three daughters[3]
Awards
Scientific career
FieldsImmunology
Rheumatology
Institutions
ThesisThe biology of complement receptors (1986)
Doctoral advisorPeter Lachmann[2]
Websitegov.uk/government/people/mark-walport

Sir Mark Jeremy Walport

The Royal Society (jointly with Alison Noble).[15]

Education

Walport is the son of a

Brompton Hospitals in London.[16][17] He was awarded a PhD for research into complement receptors under the supervision of Peter Lachmann in 1986 at the University of Cambridge.[18]

Career and research

Previously Walport was Director of the

rheumatic diseases.[19][20][21][22][23][24][25][26]

Walport was the eleventh

Government Chief Scientific Adviser from 2013 to 2017, succeeding Sir John Beddington
.

It was announced in February 2017 that Mark Walport is now Chief Executive of

UK Research and Innovation (UKRI).[13]

Honours and awards

Walport was

systemic LE and the role of complement and of defective apoptosis in its pathogenesis; and, as a general candidate, for his achievements as head of medicine at the Hammersmith Campus of Imperial College and since 2003 as Director of the Wellcome Trust. In the latter role he has provided national and international leadership at the highest level on biomedical research and policy issues and is widely recognised as a world leader in the promotion of biomedical science.[1]

References

  1. ^ a b c Anon (2011). "Sir Mark Walport". Royal Society. Retrieved 5 July 2012. One or more of the preceding sentences incorporates text from the royalsociety.org website where:

    “All text published under the heading 'Biography' on Fellow profile pages is available under Creative Commons Attribution 4.0 International License.” --Royal Society Terms, conditions and policies at the Wayback Machine (archived 2016-11-11)
  2. ^ Reed, Tanya (11 July 2003). "Wellcome to a new beginning". Reporter: The newspaper of Imperial College London. No. 131.
  3. ^
    doi:10.1093/ww/9780199540884.013.U38753. (Subscription or UK public library membership
    required.)
  4. ^
    S2CID 70581694
    .
  5. ^
    PMID 22763530
    .
  6. S2CID 11529948
    .
  7. PMID 20427555
    .
  8. PMID 22763508
    .
  9. ^ Gibney, Elizabeth (29 June 2012). "New chief scientific adviser announced". Times Higher Education.
  10. ^ Mark Walport's publications indexed by the Scopus bibliographic database. (subscription required)
  11. YouTube
  12. S2CID 3048048
    .
  13. ^ a b "Sir Mark Walport will lead UK Research and Innovation". www.gov.uk (Press release). 2 February 2017. Retrieved 4 July 2017.
  14. ^ "Dominic Cummings' science obsession: based on fact or fiction?". Times Higher Education (THE). 16 October 2019. Retrieved 25 November 2019.
  15. ^ "Council". The Royal Society. Retrieved 4 July 2023.
  16. ^ a b c "Dr Sir Mark Walport". Debrett's. Retrieved 14 February 2012.
  17. S2CID 10861093
    .
  18. EThOS uk.bl.ethos.383309
    .
  19. ^ "Mark Walport, PhD, MB. BChir., Member, Scientific Board". Grand Challenges in Global Health. Archived from the original on 27 September 2013. Retrieved 14 February 2012.
  20. PMID 22337042
    .
  21. PMID 21734685
    .
  22. S2CID 205039550
    .
  23. PMID 16769899
    .
  24. PMID 12477926
    .
  25. PMID 1350678
    .
  26. PMID 10934224
    .
  27. ^ "RSE Welcomes 60 New Fellows" (Press release). Royal Society of Edinburgh. 15 February 2017. Retrieved 28 March 2017.
  •  This article incorporates text available under the CC BY 4.0 license.
Government offices
Preceded by
Government Chief Scientific Adviser

2013−2017 		Succeeded by
Cultural offices
Preceded by Director of Wellcome Trust
2003–2013 		Succeeded by
Retrieved from "https://en.wikipedia.org/w/index.php?title=Mark_Walport&oldid=1192037868"